Invasive fungal infections in neonates: a review.

Kristin E D Weimer, P Brian Smith, Mihai Puia-Dumitrescu, Samia Aleem

Pediatric research 2022 Jan

filter terms:

aspergillus (1)

candida (1)

central catheters (1)

fungi (1)

humans (1)

infant newborn (2)

low birth weight infants (1)

mortality neonates (1)

neonates (2)

risk factors (2)

Sizes of these terms reflect their relevance to your search.

Invasive fungal infections remain the leading causes of morbidity and mortality in neonates, especially preterm and very low birth weight infants. Most invasive fungal infections are due to Candida or Aspergillus species, and other fungi are increasingly reported and described. Appropriate identification and treatment are required to augment activity and reduce the toxicity of antifungal drugs. Successful use of antifungals in the vulnerable neonatal population is important for both prevention and treatment of infection. Strategies for prevention, including prophylactic antifungal therapy as well as reducing exposure to modifiable risk factors, like limiting antibiotic exposure, discontinuation of central catheters, and hand hygiene are key techniques to prevent and decrease rates of invasive fungal infections. In conclusion, this is a review of the most common causes, prevention strategies, prophylaxis, and treatment of invasive fungal infections in neonates. © 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Citation

Kristin E D Weimer, P Brian Smith, Mihai Puia-Dumitrescu, Samia Aleem. Invasive fungal infections in neonates: a review. Pediatric research. 2022 Jan;91(2):404-412